Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Jul 2023
Historique:
received: 15 06 2023
revised: 25 07 2023
accepted: 26 07 2023
medline: 14 8 2023
pubmed: 12 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

Matrix metalloproteinases (MMPs) belong to a family of zinc-dependent proteolytic metalloenzymes. MMP-9, a member of the gelatinase B family, is characterized as one of the most intricate MMPs. The crucial involvement of MMP-9 in extracellular matrix (ECM) remodeling underscores its significant correlation with each stage of cancer pathogenesis and progression. The design and synthesis of MMP-9 inhibitors is a potentially attractive research area. Unfortunately, to date, there is no effective MMP-9 inhibitor that passes the clinical trials and is approved by the FDA. This review primarily focuses on exploring the diverse strategies employed in the design and advancement of MMP-9 inhibitors, along with their anticancer effects and selectivity. To illuminate the essential structural characteristics necessary for the future design of novel MMP-9 inhibitors, the current narrative review highlights several recently discovered MMP-9 inhibitors exhibiting notable selectivity and potency.

Identifiants

pubmed: 37569509
pii: ijms241512133
doi: 10.3390/ijms241512133
pmc: PMC10418771
pii:
doi:

Substances chimiques

Matrix Metalloproteinase 9 EC 3.4.24.35
Matrix Metalloproteinase Inhibitors 0
Matrix Metalloproteinases EC 3.4.24.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Cancer Res. 1999 Mar;5(3):513-20
pubmed: 10100701
J Med Chem. 1998 Apr 9;41(8):1209-17
pubmed: 9548812
Eur J Med Chem. 2020 Jan 15;186:111875
pubmed: 31740054
J Clin Oncol. 2002 Nov 15;20(22):4434-9
pubmed: 12431965
Cancers (Basel). 2014 Jan 27;6(1):240-96
pubmed: 24473089
Crit Rev Biochem Mol Biol. 2013 May-Jun;48(3):222-72
pubmed: 23547785
Eur J Med Chem. 2017 Mar 31;129:72-109
pubmed: 28219048
EJNMMI Radiopharm Chem. 2018 Jul 27;3:10
pubmed: 30101186
Neurobiol Dis. 2006 Mar;21(3):647-56
pubmed: 16257222
J Immunol. 2013 Apr 15;190(8):4420-30
pubmed: 23509357
Bioorg Med Chem. 2015 Jul 1;23(13):3809-18
pubmed: 25921268
Front Immunol. 2021 Nov 29;12:763832
pubmed: 34912337
PLoS One. 2017 Apr 3;12(4):e0174853
pubmed: 28369077
BMC Cancer. 2016 Oct 13;16(1):800
pubmed: 27737648
Cardiovasc Res. 2009 Jan 1;81(1):178-86
pubmed: 18852254
RSC Adv. 2021 Aug 6;11(43):26820-26831
pubmed: 35480006
Immunol Invest. 2016 Aug;45(6):543-52
pubmed: 27409770
J Neurochem. 2002 Nov;83(4):885-94
pubmed: 12421361
Tumour Biol. 2015 Aug;36(8):6053-62
pubmed: 25724188
J Med Chem. 2013 Jun 27;56(12):4912-20
pubmed: 23688254
J Biomol Struct Dyn. 2019 Aug;37(12):3135-3149
pubmed: 30079817
Bioorg Med Chem Lett. 2002 Oct 21;12(20):2867-70
pubmed: 12270165
APMIS. 1999 Jan;107(1):174-80
pubmed: 10190295
Rheumatology (Oxford). 2014 Dec;53(12):2270-9
pubmed: 24982240
J Med Chem. 2009 Oct 22;52(20):6347-61
pubmed: 19775099
J Cancer Res Ther. 2016 Jan-Mar;12(1):28-35
pubmed: 27072206
Invest New Drugs. 2006 Mar;24(2):135-40
pubmed: 16502351
Biochim Biophys Acta. 2010 Jan;1803(1):72-94
pubmed: 19712708
Cancer Res. 1993 May 1;53(9):2087-91
pubmed: 8347186
Bioorg Med Chem Lett. 2011 Nov 1;21(21):6485-90
pubmed: 21925881
Bioorg Med Chem Lett. 1998 Oct 6;8(19):2657-62
pubmed: 9873598
J Biomol Struct Dyn. 2019 Mar;37(4):944-965
pubmed: 29475408
J Comput Aided Mol Des. 2017 Jul;31(7):625-641
pubmed: 28623487
J Clin Oncol. 1998 Jun;16(6):2150-6
pubmed: 9626215
Clin Cancer Res. 1998 Apr;4(4):985-92
pubmed: 9563894
Cardiovasc Res. 2006 Feb 15;69(3):562-73
pubmed: 16405877
Mol Cell Biochem. 2006 Jul;287(1-2):109-16
pubmed: 16645725
Sci Rep. 2016 Apr 14;6:24378
pubmed: 27075045
Matrix Biol. 2019 Jan;75-76:102-113
pubmed: 29158162
Eur J Med Chem. 2020 May 15;194:112260
pubmed: 32224379
Mol Cancer Ther. 2018 Jun;17(6):1147-1155
pubmed: 29735645
Nature. 2002 Jan 31;415(6871):530-6
pubmed: 11823860
Eur J Med Chem. 2017 Dec 1;141:37-50
pubmed: 29028530
Int J Biol Macromol. 2015 Nov;81:308-15
pubmed: 26253511
J Neurosci. 2005 Jul 6;25(27):6401-8
pubmed: 16000631
J Med Chem. 2001 Sep 13;44(19):3074-82
pubmed: 11543676
Prog Mol Biol Transl Sci. 2017;147:1-73
pubmed: 28413025
Bioorg Med Chem Lett. 2003 Apr 17;13(8):1487-90
pubmed: 12668018
Cell. 2010 Apr 2;141(1):52-67
pubmed: 20371345
Int J Mol Sci. 2022 Apr 18;23(8):
pubmed: 35457257
Bioconjug Chem. 2018 Nov 21;29(11):3715-3725
pubmed: 30277751
Biochim Biophys Acta. 2010 Jan;1803(1):29-38
pubmed: 19406173
Neural Regen Res. 2014 Jun 1;9(11):1154-62
pubmed: 25206775
J Med Chem. 2003 Jun 5;46(12):2376-96
pubmed: 12773042
Eur J Med Chem. 2021 Oct 15;222:113558
pubmed: 34116327
Genet Test Mol Biomarkers. 2009 Oct;13(5):671-8
pubmed: 19814619
Arch Biochem Biophys. 1998 Jun 1;354(1):24-30
pubmed: 9633594
Pharmacol Res. 2017 Aug;122:8-19
pubmed: 28501516
Immunity. 2006 May;24(5):563-74
pubmed: 16713974
ACS Omega. 2022 Jun 09;7(24):21131-21144
pubmed: 35755386
Tumour Biol. 2014 Feb;35(2):1351-6
pubmed: 24357512
Bioorg Med Chem Lett. 2001 Apr 23;11(8):1009-13
pubmed: 11327577
Physiology (Bethesda). 2013 Nov;28(6):391-403
pubmed: 24186934
Methods Mol Biol. 2017;1520:85-106
pubmed: 27873247
Mol Biosyst. 2016 Jul 19;12(8):2519-31
pubmed: 27250644
Matrix Biol. 2015 May-Jul;44-46:207-23
pubmed: 25794647
Genes Dis. 2015 Mar 1;2(`1):26-34
pubmed: 26097889
Gynecol Oncol. 2006 Aug;102(2):300-8
pubmed: 16442153
Oncol Lett. 2017 Nov;14(5):5865-5870
pubmed: 29113219
J Med Chem. 2005 May 5;48(9):3400-9
pubmed: 15857146
J Clin Med. 2022 Jul 20;11(14):
pubmed: 35887981
Mol Inform. 2016 Jul;35(6-7):238-52
pubmed: 27492238
J Biol Chem. 2010 Nov 12;285(46):35944-56
pubmed: 20837483
Ann Oncol. 1995 Dec;6(10):967-74
pubmed: 8750146
J Med Chem. 1998 Feb 12;41(4):640-9
pubmed: 9484512
Cancer Cell. 2010 Feb 17;17(2):160-72
pubmed: 20159608
Front Mol Biosci. 2022 Mar 31;9:857430
pubmed: 35463960
Br J Cancer. 1999 Feb;79(3-4):509-14
pubmed: 10027321
Urol Oncol. 2018 Jun;36(6):272-282
pubmed: 29650324
Sensors (Basel). 2018 Sep 27;18(10):
pubmed: 30262739
World J Gastroenterol. 2006 Jan 7;12(1):105-9
pubmed: 16440426
J Med Chem. 1999 May 20;42(10):1723-38
pubmed: 10346925
Ann Oncol. 2001 Mar;12(3):389-95
pubmed: 11332153
Thromb Haemost. 2003 Oct;90(4):734-7
pubmed: 14515196
Biochim Biophys Acta. 2010 Jan;1803(1):20-8
pubmed: 19374923
Neurology. 2017 Aug 22;89(8):805-812
pubmed: 28747453
Int J Mol Sci. 2016 Jul 21;17(7):
pubmed: 27455234
Bioorg Med Chem. 2006 Sep 15;14(18):6383-403
pubmed: 16765051
Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578-82
pubmed: 2164689
Crit Rev Oncol Hematol. 2004 May;50(2):87-100
pubmed: 15157658
Clin Cancer Res. 2005 May 1;11(9):3417-24
pubmed: 15867243
Cancer Res. 1994 Sep 1;54(17):4726-8
pubmed: 8062271
Planta Med. 2004 Oct;70(10):1006-8
pubmed: 15490332
Porto Biomed J. 2018 Jul 03;3(1):e6
pubmed: 31595232
FEBS J. 2011 Jan;278(1):16-27
pubmed: 21087457
Mol Cell Proteomics. 2009 May;8(5):1044-60
pubmed: 19116209
Am J Clin Oncol. 1999 Jun;22(3):247-52
pubmed: 10362330
J Enzyme Inhib Med Chem. 2016;31(sup1):177-183
pubmed: 27028474
J Med Chem. 2015 Sep 24;58(18):7224-40
pubmed: 26263024
J Clin Oncol. 2000 Mar;18(5):1135-49
pubmed: 10694567
J Neurochem. 2016 Oct;139 Suppl 2:91-114
pubmed: 26525923
J Chem Inf Model. 2020 Jan 27;60(1):349-359
pubmed: 31825614
Int J Clin Exp Pathol. 2015 Sep 01;8(9):10452-9
pubmed: 26617754
Mol Cancer Ther. 2005 Feb;4(2):281-90
pubmed: 15713899
J Mol Graph Model. 2014 Apr;49:25-37
pubmed: 24473069
Int J Cancer. 1999 May 31;81(5):761-6
pubmed: 10328230
Neuroscience. 2012 Sep 18;220:277-90
pubmed: 22710064
Anticancer Drugs. 2005 Oct;16(9):997-1002
pubmed: 16162976
Bioorg Med Chem Lett. 2008 Jan 1;18(1):409-13
pubmed: 17981034
Org Biomol Chem. 2013 Oct 14;11(38):6623-41
pubmed: 23989288
J Biol Chem. 1999 Jul 30;274(31):21491-4
pubmed: 10419448
Aging (Albany NY). 2021 Oct 4;13(19):22867-22882
pubmed: 34607974
Cancer Res. 1995 Aug 15;55(16):3629-33
pubmed: 7627972
Front Cell Neurosci. 2015 Jul 29;9:280
pubmed: 26283917
J Med Chem. 2001 Sep 13;44(19):3066-73
pubmed: 11543675
Neuromolecular Med. 2015 Dec;17(4):385-90
pubmed: 26330106
J Med Chem. 2002 Jan 3;45(1):219-32
pubmed: 11754593
Clin Cancer Res. 1998 Aug;4(8):1899-902
pubmed: 9717817
Bioorg Med Chem. 2016 Sep 15;24(18):4291-4309
pubmed: 27452283
Pathogens. 2013 Feb 19;2(1):105-29
pubmed: 25436884
Org Biomol Chem. 2015 Jan 7;13(1):142-56
pubmed: 25348733
Bioinformation. 2011 Jan 22;5(8):310-4
pubmed: 21383916
Med Sci Monit. 2015 Apr 19;21:1115-23
pubmed: 25890491
Invest New Drugs. 1997;15(1):61-75
pubmed: 9195290
Cell Death Differ. 2003 May;10(5):558-69
pubmed: 12728254
J Biol Chem. 2008 Jul 18;283(29):20087-95
pubmed: 18499673
Mediators Inflamm. 2016;2016:7369020
pubmed: 28104930
Bioorg Med Chem Lett. 2006 Jun 15;16(12):3096-100
pubmed: 16632358
Bioorg Med Chem Lett. 1999 Jun 21;9(12):1691-6
pubmed: 10397503
Hepatogastroenterology. 1998 Jul-Aug;45(22):1056-61
pubmed: 9756006
Nat Rev Cancer. 2002 Sep;2(9):657-72
pubmed: 12209155
Braz J Med Biol Res. 2017 May 18;50(6):e6104
pubmed: 28538838
Bioorg Med Chem Lett. 2008 Feb 1;18(3):1140-5
pubmed: 18083558
J Med Chem. 2000 Feb 10;43(3):369-80
pubmed: 10669564
Cancer Cell. 2002 Oct;2(4):289-300
pubmed: 12398893
Immunol Lett. 2015 Mar;164(1):18-24
pubmed: 25639450
J Med Chem. 2012 May 24;55(10):4714-27
pubmed: 22540974
Clin Cancer Res. 2003 Feb;9(2):551-4
pubmed: 12576417
Bioorg Med Chem. 2012 Apr 1;20(7):2323-37
pubmed: 22386984
J Med Chem. 2010 Sep 23;53(18):6653-80
pubmed: 20726512
J Clin Oncol. 2005 Feb 1;23(4):842-9
pubmed: 15681529
Arch Pharm Res. 2015 Sep;38(9):1686-701
pubmed: 26208641
Bioorg Med Chem Lett. 2001 Jun 4;11(11):1465-8
pubmed: 11378378
Genomics Inform. 2023 Mar;21(1):e9
pubmed: 37037467
J Med Chem. 2003 Aug 28;46(18):3840-52
pubmed: 12930146
Bioorg Med Chem Lett. 2001 Aug 20;11(16):2189-92
pubmed: 11514167
J Biol Chem. 2017 Oct 27;292(43):17963-17974
pubmed: 28860188
FEBS Lett. 2012 Dec 14;586(24):4264-9
pubmed: 23123160
EMBO Rep. 2014 Dec;15(12):1243-53
pubmed: 25381661
Biochim Biophys Acta. 2005 May 25;1755(1):37-69
pubmed: 15907591
Clin Exp Metastasis. 2003;20(5):407-12
pubmed: 14524529
Ann Oncol. 2000 Dec;11(12):1579-84
pubmed: 11205466
Bioorg Med Chem. 2011 Aug 15;19(16):4985-99
pubmed: 21764590
Clin Exp Metastasis. 1999 Mar;17(2):111-7
pubmed: 10411102
Biochem Biophys Res Commun. 1998 Aug 10;249(1):287-91
pubmed: 9705874

Auteurs

Zainab Ahmed Rashid (ZA)

Department of Pharmaceutical Sciences, School of Pharmacy, University of Jordan, Amman 11942, Jordan.

Sanaa K Bardaweel (SK)

Department of Pharmaceutical Sciences, School of Pharmacy, University of Jordan, Amman 11942, Jordan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH